Speak with a Defective Drug Specialist
Get answers to legal & medical questions
patient advocate

 

Latest News

Date posted: 10/15/2012

October 17, 2012 – With thousands of women having filed a claim for injuries after taking the birth control drugs Yaz or Yasmin, it came as good news when Bayer recently announced it would begin settling these cases. However, a court officer has warned that time may be limited to reach a settlement.

Last year, both the British Medical Journal and FDA warned that the hormone in drugs like Yaz could increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%. The Institute for Safe Medicine Practices also ranked Yaz and Yasmin second in 2011 for the number of complications reported to the FDA.

As news of the Yaz side effects spread, more than 10,000 women sought help to file a Yaz lawsuit. Due to the number of claims, a federal Multi-District Litigation court was established in Illinois to handle the cases.

Earlier this year, Bayer announced in their annual report that they had begun settling these cases, with as many as 1900 Yaz lawsuits settled so far. They have also reserved up to $610 million to resolve more cases at an average of around $212,000.

Anyone affected by blood clots, stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights to participate in this settlement as soon as possible.

In July, the court officer appointed to oversee settlement negotiations for the federal court, special master Stephen Saltzburg, estimated the settlements could be concluded within a year.

If you or someone you love suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin, it is important to speak with a lawyer about your legal rights as soon as possible.

The Drug Resource Center cautions that victims should only seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects and litigation news related to the drug Yaz, or to speak with a lawyer, contact us today.